The significance of adverse experience, emotional processing and body perception forfunctional (pseudo-) neurological symptoms: A longitudinal study (pre-post-comparison)
Recruiting
- Conditions
- F44Dissociative [conversion] disorders
- Registration Number
- DRKS00007139
- Lead Sponsor
- niversität Konstanz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Experimental FNS Group:
At least one negative somatoform functional neurological symptom and diagnosed with a dissociative disorder by at least two neurologists / psychiatrists.
Neurological Control Group:
At least one neurological symptom and one psychiatric symptom, similar treatment / inpatient on the same ward.
Exclusion Criteria
Experimental FNS Group:
Positive somatoform functional neurological symptoms, central lesions or other central nervous illnesses
Neurological Control Group:
FNS /dissociative disorder
Healthy Comparison Group:
Neurological or psychiatric treatment and/or diagnosis in M.I.N.I. Psychiatric Screening
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Two times of measurement at the beginning and at the end of the patients' stay respectively at intervals of 4-6 weeks (healthy comparison group) with <br>(A) Standardized questions about their symptoms (SDQ-20, DES, SCL90R, SOMS, BDI, PDS), emotion processing (TAS-26, ERQ) and adverse experience (PDS, KERF, ETI) accompanied by body sensitivity measurements using transcutaneous electrical nerve stimulation (=TENS).<br>(B) Experimental measurement of emotion processing while recording and EEG/MEG (for measuring cortical alpha-desynchronisation), accompanied by body sensitivity measurements using TENS.
- Secondary Outcome Measures
Name Time Method